T-cell-derived nanovesicles produced by the serial extrusion of cytotoxic T cells through membranes with micro-/nanosized pores that inhibit T-cell exhaustion and exhibit antitumoral activity maintained in the immunosuppressive tumor microenvironment were presented.
[Advanced Materials]
6445218 {6445218:IHMGQERR} apa 50 1 164374 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-b06e51e2dd6f1a1987a93c6407c417fc%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IHMGQERR%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hong%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHong%2C%20J.%2C%20Kang%2C%20M.%2C%20Jung%2C%20M.%2C%20Lee%2C%20Y.%20Y.%2C%20Cho%2C%20Y.%2C%20Kim%2C%20C.%2C%20Song%2C%20S.%20Y.%2C%20Park%2C%20C.%20G.%2C%20Doh%2C%20J.%2C%20%26amp%3B%20Kim%2C%20B.-S.%20%28n.d.%29.%20T-Cell-Derived%20Nanovesicles%20for%20Cancer%20Immunotherapy.%20%3Ci%3EAdvanced%20Materials%3C%5C%2Fi%3E%2C%20%3Ci%3En%5C%2Fa%3C%5C%2Fi%3E%28n%5C%2Fa%29%2C%202101110.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fadma.202101110%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fadma.202101110%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DIHMGQERR%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22T-Cell-Derived%20Nanovesicles%20for%20Cancer%20Immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jihye%22%2C%22lastName%22%3A%22Hong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikyung%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mungyo%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yun%20Young%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yongbum%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheesue%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seuk%20Young%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun%20Gwon%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junsang%22%2C%22lastName%22%3A%22Doh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Byung-Soo%22%2C%22lastName%22%3A%22Kim%22%7D%5D%2C%22abstractNote%22%3A%22Although%20T-cell%20therapy%20is%20a%20remarkable%20breakthrough%20in%20cancer%20immunotherapy%2C%20the%20therapeutic%20efficacy%20is%20limited%20for%20solid%20tumors.%20A%20major%20cause%20of%20the%20low%20efficacy%20is%20T-cell%20exhaustion%20by%20immunosuppressive%20mechanisms%20of%20solid%20tumors%2C%20which%20are%20mainly%20mediated%20by%20programmed%20death-ligand%201%20%28PD-L1%29%20and%20transforming%20growth%20factor-beta%20%28TGF-%5Cu03b2%29.%20Herein%2C%20T-cell-derived%20nanovesicles%20%28TCNVs%29%20produced%20by%20the%20serial%20extrusion%20of%20cytotoxic%20T%20cells%20through%20membranes%20with%20micro-%5C%2Fnanosized%20pores%20that%20inhibit%20T-cell%20exhaustion%20and%20exhibit%20antitumoral%20activity%20maintained%20in%20the%20immunosuppressive%20tumor%20microenvironment%20%28TME%29%20are%20presented.%20TCNVs%2C%20which%20have%20programmed%20cell%20death%20protein%201%20and%20TGF-%5Cu03b2%20receptor%20on%20their%20surface%2C%20block%20PD-L1%20on%20cancer%20cells%20and%20scavenge%20TGF-%5Cu03b2%20in%20the%20immunosuppressive%20TME%2C%20thereby%20preventing%20cytotoxic-T-cell%20exhaustion.%20In%20addition%2C%20TCNVs%20directly%20kill%20cancer%20cells%20via%20granzyme%20B%20delivery.%20TCNVs%20successfully%20suppress%20tumor%20growth%20in%20syngeneic-solid-tumor-bearing%20mice.%20Taken%20together%2C%20TCNV%20offers%20an%20effective%20cancer%20immunotherapy%20strategy%20to%20overcome%20the%20tumor%27s%20immunosuppressive%20mechanisms.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Fadma.202101110%22%2C%22ISSN%22%3A%221521-4095%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Fadma.202101110%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-08T17%3A28%3A41Z%22%7D%7D%5D%7D
Hong, J., Kang, M., Jung, M., Lee, Y. Y., Cho, Y., Kim, C., Song, S. Y., Park, C. G., Doh, J., & Kim, B.-S. (n.d.). T-Cell-Derived Nanovesicles for Cancer Immunotherapy. Advanced Materials, n/a(n/a), 2101110. https://doi.org/10.1002/adma.202101110 Cite